268 related articles for article (PubMed ID: 18338371)
1. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
[TBL] [Abstract][Full Text] [Related]
2. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
[TBL] [Abstract][Full Text] [Related]
4. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
5. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
[TBL] [Abstract][Full Text] [Related]
7. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice.
Qi Z; Pan C; Lu H; Shui Y; Li L; Li X; Xu X; Liu S; Jiang S
Biochem Biophys Res Commun; 2010 Jul; 398(3):506-12. PubMed ID: 20599765
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
[TBL] [Abstract][Full Text] [Related]
10. Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes.
Zipeto D; Matucci A; Ripamonti C; Scarlatti G; Rossolillo P; Turci M; Sartoris S; Tridente G; Bertazzoni U
Microbes Infect; 2006 May; 8(6):1424-33. PubMed ID: 16702010
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.
Opalka D; Pessi A; Bianchi E; Ciliberto G; Schleif W; McElhaugh M; Danzeisen R; Geleziunas R; Miller M; Eckert DM; Bramhill D; Joyce J; Cook J; Magilton W; Shiver J; Emini E; Esser MT
J Immunol Methods; 2004 Apr; 287(1-2):49-65. PubMed ID: 15099755
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41.
Taniguchi Y; Zolla-Pazner S; Xu Y; Zhang X; Takeda S; Hattori T
Virology; 2000 Aug; 273(2):333-40. PubMed ID: 10915604
[TBL] [Abstract][Full Text] [Related]
15. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
Cleveland SM; Jones TD; Dimmock NJ
J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
[TBL] [Abstract][Full Text] [Related]
16. Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles.
Zhang H; Huang Y; Fayad R; Spear GT; Qiao L
J Virol; 2004 Aug; 78(15):8342-8. PubMed ID: 15254206
[TBL] [Abstract][Full Text] [Related]
17. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
[TBL] [Abstract][Full Text] [Related]
18. Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope.
Li J; Chen X; Jiang S; Chen YH
Biochem Biophys Res Commun; 2008 Nov; 376(1):60-4. PubMed ID: 18762167
[TBL] [Abstract][Full Text] [Related]
19. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.
Benferhat R; Krust B; Rey-Cuillé MA; Hovanessian AG
Vaccine; 2009 Jun; 27(27):3620-30. PubMed ID: 19464543
[TBL] [Abstract][Full Text] [Related]
20. Antiviral properties of two trimeric recombinant gp41 proteins.
Delcroix-Genête D; Quan PL; Roger MG; Hazan U; Nisole S; Rousseau C
Retrovirology; 2006 Mar; 3():16. PubMed ID: 16515685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
